Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06587074
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-09-04
Brief Title:
Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary Hypertension When Using Modern Strategies of Specific Therapy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will be performed based on a retrospective analysis of the cases of 150-170 patients with IPAH observed at the Research Institute of Clinical Cardiology over the past 10 years for a comparative assessment of the survival of groups of patients with IPAH diagnosed in the period 2004-2013 and 2014-2023
The demographic clinical functional hemodynamic characteristics of patients comorbidity blood biomarker levels received PAH-specific and symptomatic therapy will be assessed in order to determine the clinical characteristics of patients with IPAH
The prospective part of study will include 50 patients with IPAH
The demographic clinical functional hemodynamic characteristics of patients comorbidity blood biomarker levels received PAH-specific and symptomatic therapy will be assessed in order to determine the clinical characteristics of patients with IPAH
The prospective part of study will include 50 patients with IPAH
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None